User profiles for Richard Wunderink
Richard Glenn WunderinkNorthwestern University Verified email at northwestern.edu Cited by 39831 |
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
LA Mandell, RG Wunderink, A Anzueto… - Clinical infectious …, 2007 - academic.oup.com
Improving the care of adult patients with community-acquired pneumonia (CAP) has been
the focus of many different organizations, and several have developed guidelines for …
the focus of many different organizations, and several have developed guidelines for …
MERS, SARS and other coronaviruses as causes of pneumonia
Y Yin, RG Wunderink - Respirology, 2018 - Wiley Online Library
Human coronaviruses (HCoVs) have been considered to be relatively harmless respiratory
pathogens in the past. However, after the outbreak of the severe acute respiratory syndrome (…
pathogens in the past. However, after the outbreak of the severe acute respiratory syndrome (…
[HTML][HTML] Community-acquired pneumonia requiring hospitalization among US adults
S Jain, WH Self, RG Wunderink… - … England Journal of …, 2015 - Mass Medical Soc
Background Community-acquired pneumonia is a leading infectious cause of hospitalization
and death among US adults. Incidence estimates of pneumonia confirmed radiographically …
and death among US adults. Incidence estimates of pneumonia confirmed radiographically …
Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter …
Objective. —To evaluate the efficacy and safety of anti—tumor necrosis factor α monoclonal
antibody (TNF-α MAb) in the treatment of patients with sepsis syndrome. Design. —…
antibody (TNF-α MAb) in the treatment of patients with sepsis syndrome. Design. —…
[HTML][HTML] Community-acquired pneumonia requiring hospitalization among US children
…, E Schneider, LA Hicks, RG Wunderink… - … England Journal of …, 2015 - Mass Medical Soc
Background Incidence estimates of hospitalizations for community-acquired pneumonia
among children in the United States that are based on prospective data collection are limited. …
among children in the United States that are based on prospective data collection are limited. …
[HTML][HTML] Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
Some patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
develop severe pneumonia and acute respiratory distress syndrome 1 (ARDS). Distinct …
develop severe pneumonia and acute respiratory distress syndrome 1 (ARDS). Distinct …
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the …
…, JF Timsit, T Welte, R Wunderink - European …, 2017 - Eur Respiratory Soc
The most recent European guidelines and task force reports on hospital-acquired pneumonia
(HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. …
(HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. …
Factors associated with death in critically ill patients with coronavirus disease 2019 in the US
Importance The US is currently an epicenter of the coronavirus disease 2019 (COVID-19)
pandemic, yet few national data are available on patient characteristics, treatment, and …
pandemic, yet few national data are available on patient characteristics, treatment, and …
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE …
…, K Toyoizumi, RG Wunderink… - The Lancet infectious …, 2021 - thelancet.com
Background New antibiotics are needed for the treatment of patients with life-threatening
carbapenem-resistant Gram-negative infections. We assessed the efficacy and safety of …
carbapenem-resistant Gram-negative infections. We assessed the efficacy and safety of …
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
…, G Gutierrez, S Tessler, G San Pedro, R Wunderink… - The Lancet, 1998 - thelancet.com
Background Despite the availability of potent antibiotics and intensive care, mortality rates
from septic shock are 40–70%. We assessed the safety and efficacy of murine monoclonal …
from septic shock are 40–70%. We assessed the safety and efficacy of murine monoclonal …